Emmanuelle Tresch
Papers
1
Total Citations
25
H-Index
1
About
Emmanuelle Tresch is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic radiotherapy for intracranial tumors. Her major contributions center on optimizing treatment regimens for meningiomas, particularly through the evaluation of hypofractionated stereotactic radiotherapy (hFSRT). In her landmark 2018 study, Tresch assessed the efficacy and tolerance of robotic hFSRT in a substantial cohort of 126 patients with 136 intracranial meningiomas, demonstrating that this approach achieves excellent local control while minimizing toxicity. This work, cited 25 times, has provided critical evidence for refining radiotherapy protocols and expanding non-invasive treatment options for complex brain tumors. Tresch’s research directly impacts clinical decision-making, offering patients a precise, well-tolerated alternative to conventional fractionation. Her dedication to advancing stereotactic techniques underscores her role as a key contributor to modern neuro-oncology, shaping safer and more effective radiation strategies for meningioma management.
Research Focus
Key Achievements
Top Papers
- 1